KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Cash & Current Investments (2018 - 2026)

Castle Biosciences' Cash & Current Investments history spans 8 years, with the latest figure at $299.5 million for Q4 2025.

  • On a quarterly basis, Cash & Current Investments rose 2.17% to $299.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $299.5 million, a 2.17% increase, with the full-year FY2025 number at $299.5 million, up 2.17% from a year prior.
  • Cash & Current Investments hit $299.5 million in Q4 2025 for Castle Biosciences, up from $287.5 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for CSTL hit a ceiling of $407.0 million in Q1 2021 and a floor of $225.5 million in Q2 2023.
  • Historically, Cash & Current Investments has averaged $285.8 million across 5 years, with a median of $275.5 million in 2025.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 312.54% in 2021 and later dropped 26.76% in 2022.
  • Tracing CSTL's Cash & Current Investments over 5 years: stood at $329.6 million in 2021, then decreased by 21.54% to $258.6 million in 2022, then dropped by 6.0% to $243.1 million in 2023, then increased by 20.58% to $293.1 million in 2024, then grew by 2.17% to $299.5 million in 2025.
  • Business Quant data shows Cash & Current Investments for CSTL at $299.5 million in Q4 2025, $287.5 million in Q3 2025, and $275.9 million in Q2 2025.